{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:49Z","timestamp":1761847729243,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lilly, Pozen"},{"name":"CSL"},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004339","name":"sanofi-aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Haemoscope"},{"name":"Medtronic"},{"name":"Harvard Clinical Research Institute"},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Accumetrics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jcin.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T16:01:46Z","timestamp":1373904106000},"page":"684-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["P2Y12Receptor Blockade and Myocardial Perfusion"],"prefix":"10.1016","volume":"6","author":[{"given":"Paul A.","family":"Gurbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2013.04.006_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/14779072.2.4.535","article-title":"Platelet activation in myocardial ischemic syndromes","volume":"2","author":"Gurbel","year":"2004","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jcin.2013.04.006_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","article-title":"Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death","volume":"73","author":"Davies","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.04.006_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","article-title":"Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs","volume":"101","author":"Gibson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.04.006_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcin.2013.03.014","article-title":"Angiographic outcomes in the PLATO Trial (platelet inhibition and patients outcomes)","volume":"6","author":"Kunadian","year":"2013","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2013.04.006_bib5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/ehl149","article-title":"Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy","volume":"27","author":"Kirtane","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2013.04.006_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005344-200304000-00011","article-title":"Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates","volume":"41","author":"Moser","year":"2003","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jcin.2013.04.006_bib7","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2005.12.077","article-title":"A\u00a0randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial","volume":"47","author":"Gibson","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.04.006_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2005.11.012","article-title":"Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial","volume":"47","author":"Bolognese","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.04.006_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000137912.11655.F6","volume":"110","author":"Gibson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.04.006_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1538-7836.2010.04144.x","article-title":"Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood","volume":"9","author":"Mendolicchio","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jcin.2013.04.006_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2009.10.010","volume":"158","author":"Berger","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2013.04.006_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ahj.2007.06.001","volume":"154","author":"Greenbaum","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2013.04.006_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI\u00a0on ischemic events","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.04.006_bib14","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.04.006_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323","article-title":"Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction","volume":"5","author":"Alexopoulos","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2013.04.006_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","article-title":"Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans","volume":"61","author":"Wittfeldt","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813008108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813008108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:59:03Z","timestamp":1761847143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879813008108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1936879813008108"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2013.04.006","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12Receptor Blockade and Myocardial Perfusion","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2013.03.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}